Advertisement
Advertisement
U.S. markets open in 5 hours 37 minutes
Advertisement
Advertisement
Advertisement
Advertisement

ALR Technologies Inc. (ALRT)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.05390.0000 (0.00%)
At close: 11:16AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0539
Open0.0538
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0539 - 0.0539
52 Week Range0.0450 - 0.0700
Volume28,000
Avg. Volume108,654
Market Cap29.252M
Beta (5Y Monthly)2.96
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ALRT

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ALR TECHNOLOGIES INC
    The Argus Min Vol Model PortfolioThe onset of the coronavirus in 2020 knocked stocks into a bear market. Though equities recovered, the U.S. economy is about to slow down and COVID-19 cases are rising again as virus variants spread. Volatility, which has dropped from the highs of 2020, still has not returned to pre-COVID levels. Daily prices can swing wildly, as they did three times in 2021 when stocks dropped 4%-5% in a matter of a few days. Is it time for investors to cash in their chips? We note that investors exit the stock market at their own peril, as long-term returns from equities consistently have outpaced long-term returns from other asset classes, such as fixed income and cash. As well, those returns are from eras when the 10-year Treasury bond yield was not sub-2.0%. So what's a potential equity strategy for investors amid all the uncertainty? Argus believes that Min Vol is an all-weather strategy that is timely in any investing climate. Academic literature and, more to the point, returns history indicate that Min Vol can deliver market-matching returns on an absolute basis and superior returns on a risk-adjusted basis over various time periods.
    Rating
    Fair Value
    Economic Moat
    20 hours agoArgus Research
View more
  • GlobeNewswire

    ALR Technologies Releases an Open Letter to Shareholders

    SINGAPORE, Dec. 20, 2021 (GLOBE NEWSWIRE) -- ALR Technologies (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes management company, today releases an open letter to shareholders from Chairman and Chief Executive Officer Sidney Chan. A copy of the letter is presented in this press release, the original can be found at https://alrt.com/investors/2021lettertoshareholders. Dear Fellow Shareholders,2021 has been a transformative year for ALRT within which we have accomplished many important miles

  • GlobeNewswire

    ALR Technologies and Infinovo Sign Memorandum of Understanding to Manufacture World’s First CGM for Diabetic Pets

    SINGAPORE, Dec. 07, 2021 (GLOBE NEWSWIRE) -- ALR Technologies (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes management company, is pleased to announce the signing of a Memorandum of Understanding (“MOU”) with Infinovo Medical Co. Ltd for a global supply agreement of their P3 Continuous Glucose Monitor (CGM) for use by ALRT in the animal health sector. Under the terms of the MOU, ALR Technologies and Infinovo will collaborate to integrate Infinovo’s P3 CGM with ALRT’s proprietary GluCurve

  • GlobeNewswire

    ALR Technologies Releases Select Results from Market Research on Diabetic Pet Industry; Market Demand High for Innovation

    GluCurve is the world’s first continuous glucose monitor (CGM) for diabetic dogs and catsGluCurve eliminates need for manual, costly and cumbersome “glucose curves” that are today’s standard of care2017 AVMA Report shows between 28,000-32,000 veterinary practices in U.S.97% of DVM survey respondents indicated they’d use a pet CGM system to diagnose and manage diabetic dogs and cats as soon as available SINGAPORE, Oct. 21, 2021 (GLOBE NEWSWIRE) -- ALR Technologies (“ALRT” or the “Company”) (OTCQB

Advertisement
Advertisement